Effects of Skeleton Structure of Mesoporous Silica Nanoadjuvants on Cancer Immunotherapy.

Mesoporous silica nanoparticles (MSNs) have been widely praised as nanoadjuvants in vaccine/tumor immunotherapy thanks to their excellent biocompatibility, easy-to-modify surface, adjustable particle size, and remarkable immuno-enhancing activity. However, the application of MSNs is still greatly limited by some severe challenges including the unclear and complicated relationships of structure and immune effect. Herein, three commonly used MSNs with different skeletons including MSN with tetrasulfide bonds (TMSN), MSN containing ethoxy framework (EMSN), and pure -Si-O-Si- framework of MSN (MSN) are comprehensively compared to study the impact of chemical construction on immune effect. The results fully demonstrate that the three MSNs have great promise in improving cellular immunity for tumor immunotherapy. Moreover, the TMSN performs better than the other two MSNs in antigen loading, cellular uptake, reactive oxygen species (ROS) generation, lymph node targeting, immune activation, and therapeutic efficiency. The findings provide a new paradigm for revealing the structure-function relationship of mesoporous silica nanoadjuvants, paving the way for their future clinical application.

[1]  Ping'an Ma,et al.  ZIF-8 Nanoparticles Evoke Pyroptosis for High-Efficiency Cancer Immunotherapy. , 2023, Angewandte Chemie.

[2]  V. Sarafian,et al.  Redox regulation of the immune response , 2022, Cellular & Molecular Immunology.

[3]  Qiaobing Xu,et al.  Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Mingyu Xia,et al.  Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy , 2022, Asian journal of pharmaceutical sciences.

[5]  Jibiao Wu,et al.  New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Yannan Yang,et al.  Nanostructured Organosilica Nitric Oxide Donors Intrinsically Regulate Macrophage Polarization with Antitumor Effect. , 2022, ACS nano.

[7]  Jun Lin,et al.  Mn2+/Fe3+/Co2+ and Tetrasulfide Bond Co‐Incorporated Dendritic Mesoporous Organosilica as Multifunctional Nanocarriers: One‐Step Synthesis and Applications for Cancer Therapy , 2022, Advanced Healthcare Materials.

[8]  Jiajun Fu,et al.  Chemically engineered mesoporous silica nanoparticles-based intelligent delivery systems for theranostic applications in multiple cancerous/non-cancerous diseases , 2022, Coordination Chemistry Reviews.

[9]  Jun Lin,et al.  Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy , 2022, Advanced Functional Materials.

[10]  S. Thayumanavan,et al.  Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation. , 2021, ACS applied materials & interfaces.

[11]  Yixian Zhou,et al.  Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. , 2021, Biomaterials.

[12]  Jiangkang Xu,et al.  Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment. , 2021, ACS nano.

[13]  Y. Liu,et al.  Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus , 2021, Nano Today.

[14]  Jianguo Wang,et al.  Targeting tumor-associated macrophages to synergize tumor immunotherapy , 2021, Signal Transduction and Targeted Therapy.

[15]  Juan Li,et al.  Disulfide-Containing Molecular Sticker Assists Cellular Delivery of DNA Nanoassemblies by Bypassing Endocytosis , 2020 .

[16]  I. Nakase,et al.  Association of Hydrophobic Carboxyl-Terminal Dendrimers with Lymph Node-Resident Lymphocytes , 2020, Polymers.

[17]  Jun Lin,et al.  MnOx Nanospikes as Nanoadjuvants and Immuogenic Cell Death Drugs with Enhanced Antitumor Immunity and Antimetastatic Effect. , 2020, Angewandte Chemie.

[18]  Xiaofang Zhong,et al.  The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency , 2020, Science Advances.

[19]  Huiyin Lan,et al.  Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications , 2019, Journal of Hematology & Oncology.

[20]  Shiho Yada,et al.  Adsorption and aggregation properties of alkoxy-group-modified homogeneous polyoxyethylene alkyl ether nonionic surfactants , 2019, Journal of Molecular Liquids.

[21]  Zhihui Liang,et al.  Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. , 2019, Vaccine.

[22]  Janine K. Tom,et al.  Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development. , 2019, Trends in biotechnology.

[23]  Jun Lin,et al.  Large‐Pore Mesoporous‐Silica‐Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy , 2018, Advanced materials.

[24]  S. Yao,et al.  Bypassing Endocytosis: Direct Cytosolic Delivery of Proteins. , 2018, Journal of the American Chemical Society.

[25]  Bo Wan,et al.  A nano silicon adjuvant enhances inactivated transmissible gastroenteritis vaccine through activation the Toll-like receptors and promotes humoral and cellular immune responses. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[26]  R. Zhang,et al.  Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response. , 2018, ACS biomaterials science & engineering.

[27]  Hongyan Ma,et al.  Precision‐porous templated scaffolds of varying pore size drive dendritic cell activation , 2018, Biotechnology and bioengineering.

[28]  D. Zhao,et al.  Facile Synthesis of Uniform Virus-like Mesoporous Silica Nanoparticles for Enhanced Cellular Internalization , 2017, ACS central science.

[29]  I. Frazer,et al.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity , 2017, Cell Death & Disease.

[30]  C. Palivan,et al.  Strain-Promoted Thiol-Mediated Cellular Uptake of Giant Substrates: Liposomes and Polymersomes. , 2017, Angewandte Chemie.

[31]  W. Urba,et al.  The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation , 2017, Nanoscale Research Letters.

[32]  Karl Winkler,et al.  Accumulating nanoparticles by EPR: A route of no return. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[33]  T. Ohno,et al.  Silica Nanospheres: Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo (Small 26/2016). , 2016, Small.

[34]  T. Ohno,et al.  Comprehensive Mechanism Analysis of Mesoporous‐Silica‐Nanoparticle‐Induced Cancer Immunotherapy , 2016, Advanced healthcare materials.

[35]  Meredith O'Keeffe,et al.  Human dendritic cell subsets and function in health and disease , 2015, Cellular and Molecular Life Sciences.

[36]  T. Ohno,et al.  Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy. , 2014, Journal of biomedical materials research. Part A.

[37]  V. Apostolopoulos,et al.  Targeting Antigens to Dendritic Cell Receptors for Vaccine Development , 2013, Journal of drug delivery.

[38]  J. Hubbell,et al.  Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. , 2012, Vaccine.

[39]  S. Gabrielsson,et al.  Adjuvant properties of mesoporous silica particles tune the development of effector T cells. , 2012, Small.

[40]  James J Moon,et al.  Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.

[41]  A. Torres,et al.  Exploiting cell surface thiols to enhance cellular uptake. , 2012, Trends in biotechnology.

[42]  P. Carmeliet,et al.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. , 2011, Cancer cell.

[43]  R. Coffman,et al.  Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.